That the Senate—
designates July 16, 2025, as “Glioblastoma Awareness Day”;
encourages increased public awareness of glioblastoma;
honors the individuals who have died from the devastating disease of glioblastoma or are currently living with the disease;
supports efforts to develop better treatments for glioblastoma that will improve the long-term prognosis for, and the quality of life of, individuals diagnosed with the disease;
recognizes the importance of molecular biomarker testing to the diagnosis and treatment of glioblastoma;
expresses support for the individuals who are battling brain tumors, as well as the families, friends, and caregivers of those individuals;
urges a collaborative approach to brain tumor research among governmental, private, and nonprofit organizations, which is a promising means of advancing the understanding and treatment of glioblastoma; and
encourages continued investments in glioblastoma research and treatments, including through the Glioblastoma Therapeutics Network and other existing brain tumor research resources.